Camille V Edwards

Has grant

Assistant Professor of Medicine

Boston University School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Camille V Edwards is an Assistant Professor of Medicine at Boston University School of Medicine and Boston Medical Center in the United States. Her research focuses on the prognostic factors and treatment outcomes in hematological malignancies, particularly in older veterans and patients with multiple myeloma and AL amyloidosis. Recent articles highlight her investigations into the predictive value of various clinical markers and the safety and efficacy of treatment regimens in these populations.

Recent Grants

Grant: Close

Defining a molecular signature of cardiac tissue dysfunction in systemic immunoglobulin light-chain amyloidosis

Open Date:

Close Date:

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (6)

Nathanael Fillmore

Assistant Professor of Medicine

Harvard Medical School

UNITED STATES

View details

Deepa M. Gopal

UNITED STATES

View details

Hamza Hassan

Boston University

UNITED STATES

View details

K. H. Vincent Lau

Boston University School of Medicine

UNITED STATES

View details

Michelle Kaku

Assistant Professor of Neurology

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

Raphael Szalat

Assistant professor

Boston University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Camille V Edwards

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia

Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma

Abnormal global longitudinal strain and reduced serum inflammatory markers in cardiac AL amyloidosis patients without significant amyloid fibril deposition

Febrile neutropenia in patients with Duffy-null–associated neutrophil counts and multiple myeloma or AL amyloidosis

Peripheral blood monocyte count is a dynamic prognostic biomarker in multiple myeloma.

Clinical Reasoning: A 23-Year-Old Man With Progressive Asymmetric Weakness and Numbness

Clinical Reasoning: A 67-Year-Old Woman With Progressive Tingling Sensations and Imbalance

Safety and Efficacy of Propylene Glycol-Free Melphalan in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Results of a Phase II Study

WHIM Syndrome: First Reported Case in a Patient of African Ancestry

Validation of algorithms to select patients with multiple myeloma and patients initiating myeloma treatment in the national Veterans Affairs Healthcare System.

Modified High-Dose versus High-Dose Melphalan Conditioning in Older Patients Undergoing Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study.

The impact of substance use on health care utilization, treatment, and outcomes in patients with non-small cell lung cancer

Phase 1a/b study of monoclonal antibody CAEL-101 (11-1F4) in patients with AL amyloidosis

Collaborators (6)

Nathanael Fillmore

Deepa M. Gopal

Hamza Hassan

K. H. Vincent Lau

Michelle Kaku

Raphael Szalat

Make your next move.